母亲妊娠期糖尿病、1型及2型糖尿病与子代ADHD风险
该回顾性出生队列纳入1995-2012年Kaiser Permanente南加州医院分娩的333182例单胎,随访至4岁后中位4.9年。子代ADHD风险与GDM整体无关(P=0.50),但需抗糖尿病药物治疗的GDM、T1D和T2D暴露均显著增加风险,且风险呈T1D>T2D>需用药GDM的层级。
要点
- 母亲T1D暴露子代ADHD风险最高(aHR 1.57,95%CI 1.09-2.25)。
- 需抗糖尿病药物治疗的GDM增加ADHD风险(aHR 1.26,95%CI 1.14-1.41)。
- 不需药物治疗的GDM与ADHD风险无关(aHR 0.93,95%CI 0.86-1.01)。
核心结论
- 母亲糖尿病严重程度影响子代ADHD风险,风险层级为T1D > T2D > 需抗糖尿病药物的GDM。
- GDM整体及GDM诊断孕周与子代ADHD风险无显著关联。
研究设计与样本
- 回顾性出生队列研究,纳入1995-2012年Kaiser Permanente南加州医院出生的333182例单胎。
- 子代自4岁起通过电子病历前瞻性随访,采用Cox回归估计风险比并校正潜在混杂因素。
主要发现
- 37878例(11.4%)子代暴露于糖尿病,其中T1D 522例、T2D 7822例、GDM 29534例。
- 4岁后中位随访4.9年(四分位距2.2-9.6年),17415例(5.2%)子代诊断为ADHD。
- 与未暴露子代相比,T1D暴露aHR 1.57(95%CI 1.09-2.25),T2D暴露aHR 1.43(95%CI 1.29-1.60)。
- 需抗糖尿病药物的GDM暴露aHR 1.26(95%CI 1.14-1.41),不需药物者aHR 0.93(95%CI 0.86-1.01)。
- GDM整体与ADHD风险无关(P=0.50),GDM诊断孕周亦无关(P=0.16),但GDM是否需药物治疗间差异显著(P<0.001)。
临床怎么用
- 对母亲孕前T1D、T2D或孕期需抗糖尿病药物治疗的GDM子代,应关注ADHD相关行为表现并适时评估。
- 不需药物治疗的GDM子代ADHD风险未见升高,可据此分层管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the relative importance of maternal preexisting type 1 diabetes (T1D), preexisting type 2 diabetes (T2D), and gestational diabetes mellitus (GDM) on risk of attention deficit/hyperactivity disorder (ADHD) in offspring. RESEARCH DESIGN AND METHODS: This retrospective birth cohort study included 333,182 singletons born in 1995-2012 within Kaiser Permanente Southern California hospitals. Children were prospectively followed through electronic medical records from age 4 years. Relative risks of ADHD associated with diabetes exposures in utero were estimated by hazard ratios (HRs) using Cox regression with adjustment for potential confounders. For GDM, timing of exposure was evaluated by gestational age at diagnosis and severity was assessed by the need for antidiabetes medication treatment during pregnancy. RESULTS: A total of 37,878 (11.4%) children were exposed to diabetes (522 exposed to T1D, 7,822 T2D, and 29,534 GDM). During a median of 4.9 years (interquartile range 2.2, 9.6) of follow-up after age 4 years, 17,415 (5.2%) children were diagnosed with ADHD. ADHD risk was not associated with GDM taken as a whole (P = 0.50) or with gestational age at GDM diagnosis (P = 0.16). However, the risk was significantly greater for the GDM requiring versus not requiring antidiabetes medications (P < 0.001). Compared with children unexposed to diabetes, the adjusted HRs for ADHD in children were 1.57 (95% CI 1.09-2.25) for exposure to T1D, 1.43 (1.29-1.60) for T2D, 1.26 (1.14-1.41) for GDM requiring antidiabetes medications, and 0.93 (0.86-1.01) for GDM not requiring medications. CONCLUSIONS: The hierarchy of risks suggests that severity of maternal diabetes (T1D vs. T2D vs. GDM requiring antidiabetes medications) influences the risk of ADHD in offspring of mothers with diabetes.
引用
- Xiang AH, Wang X, Martinez MP, et al. Maternal Gestational Diabetes Mellitus, Type 1 Diabetes, and Type 2 Diabetes During Pregnancy and Risk of ADHD in Offspring. Diabetes Care. 2018. PMID: 30373735. doi:10.2337/dc18-0733
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。